Dr. Chauhan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1120 NW 14th st
Miami, FL 33136
Summary
- Aman Chauhan, MD, earned his medical degree from the Kasturba Medical College in Manipal, Karnataka, India, followed by a dual residency in internal medicine and pediatrics at Louisiana State University in New Orleans. Dr. Chauhan completed his fellowship in hematology and oncology at the University of Kentucky, especially focusing on neuroendocrine tumor (NETs). Additionally, Dr. Chauhan completed a Cancer Therapy Evaluation Program (CTEP) physician externship at the National Cancer institute (NCI) that focused on designing clinical trials and clinical research projects.
His clinical interests include treating NETs, including carcinoid tumors, high-grade neuroendocrine carcinomas, and small and large cell neuroendocrine carcinoma. Dr Chauhan leads the University of Miami Neuroendocrine Cancer Program and he is national principal investigator on several investigator-initiated neuroendocrine cancer theranostics clinical trials. He has authored over 80 scientific publications and book chapters and has received career development awards from National Cancer Institute. Dr. Chauhan also serves on AJCC and ASCO NET guideline committees and is an active member of NANETS communication committee.
Dr. Chauhan is board certified in internal medicine and medical oncology. He is a member of the American Society of Clinical Oncology as well as the American Association of Cancer Research and the North American Neuroendocrine Tumor Society.
Education & Training
- University of Kentucky College of MedicineFellowship, Hematology and Medical Oncology, 2015 - 2018
- Louisiana State University School of MedicineResidency, Pediatrics, 2011 - 2015
- Kasturba Medical College ManipalClass of 2010
Certifications & Licensure
- FL State Medical License 2022 - 2025
- KY State Medical License 2015 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma Start of enrollment: 2019 Sep 04
- Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors Start of enrollment: 2020 Jul 20
- Telotristat With Lutathera in Neuroendocrine Tumors Start of enrollment: 2021 Sep 13
- Join now to see all
Publications & Presentations
PubMed
- 27 citationsImmunotherapy for Medulloblastoma: Current PerspectivesTanvir Kabir, Charles A. Kunos, John L. Villano, Aman Chauhan
Immunotargets and Therapy. 2020-04-20 - 22 citationsManagement of Large Cell Neuroendocrine Carcinoma.Virginia Corbett, Susanne M. Arnold, Lowell Anthony, Aman Chauhan
Frontiers in Oncology. 2021-08-27 - 22 citationsNeuroendocrine Tumors-Less Well Known, Often Misunderstood, and Rapidly Growing in Incidence.Aman Chauhan, Elise C. Kohn, Jaydira Del Rivero
JAMA Oncology. 2020-01-01
Press Mentions
- UPDATE: Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at the North American Neuroendocrine Tumor Society (NANETS) Annual MeetingNovember 14th, 2024
- Crinetics Pharmaceuticals to Showcase Pipeline Advancements with Neuroendocrine Tumor Candidates at the North American Neuroendocrine Tumor Society (NANETS) Annual MeetingNovember 12th, 2024
- Moffitt Initiates Groundbreaking Clinical Trial with Oncolytic Virus for Non-Small Cell Lung CancerApril 30th, 2024
- Join now to see all
External Links
- UK Healthcarehttps://ukhealthcare.uky.edu/doctors/aman-chauhan
- NETCONNECThttps://net-connect.info/meet-the-experts/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: